Press about Movetis
Movetis NV, of Turnhout, Belgium, obtained approval from the European Commission to commercialize Resolor ...
Read more >
Movetis hat von der Europäischen Kommission die Zulassung für die Vermarktung seines Produkts Prucalopride ...
Read more >
Movetis announced that it has obtained approval from the European Commission for the commercialisation ...
Read more >
Die belgische Movetis will noch vor Jahresende an die Brüsseler Börse. Wie die Tageszeitung "De Standaard" ...
Read more >
Big Pharma has largely eschewed the risk-reward profile associated with many gastrointestinal drugs. ...
Read more >